Evidence map›Paper›PMID 22784302›Full record

ArticleGenetic testing and molecular biomarkers2012

A novel variation of PLAGL1 in Chinese patients with isolated ventricular septal defect.

Chao Xuan, Bin-Bin Wang, Ge Gao, Xiao-Yan Bai, Qin Yang, Xiao-Cheng Liu, Wen-Bin Jing, Xu Ma, Guo-Wei He

Open access · greenAbstract read
In one paragraph

Article in Genetic testing and molecular biomarkers, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Chao XuanTEDA International Cardiovascular Hospital, Medical College, Nankai University, Tianjin, PR China.
Bin-Bin Wang
Ge Gao
Xiao-Yan Bai
Qin Yang
Xiao-Cheng Liu
Wen-Bin Jing
Xu Ma
Guo-Wei He
Nankai University · CNChina National Petroleum and Chemical Planning Institute · CNChinese University of Hong Kong · HKOregon Health & Science University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsVentricular septal defect (VSD) is the most common congenital heart disease (CHD). A number of genetic studies have linked the gene of PLAGL1 to the etiology of CHD. The present study aimed to identify potential pathogenic mutations for PLAGL1 and to provide insights into the etiology of isolated VSD.

methodsCase-control mutational analysis was performed in 300 patients with isolated VSD and 300 healthy controls. Two protein-coding extons of PLAGL1 and their partial flanking intron sequences were amplified by polymerase chain reaction and sequenced on an ABI3730 Automated Sequencer. CLC workbench software was used to compare the conservatism of PLAGL1 protein with other multiple species.

resultsNeither missense nor frame-shift mutations were detected in two protein-coding extons of PLAGL1. But a novel synonymous variation (c.486A>G, p. E162E) was detected in protein-coding exon-2. The glutamic that translated with the mutational codon is conservative when compared with other species.

conclusionsWe detected a synonymous variation in the protein-coding exon-2 of PLAGL1 in isolated VSD patients. It is possible that the etiology of isolated VSD might not be directly linked with this mutation, but might be associated with other patterns of gene expression regulation in PLAGL1, such as in the methylation-dependent manner.

Indexed as

Base SequenceCase-Control StudiesCell Cycle ProteinsChinaDNA PrimersHeart Septal Defects, VentricularHumansIntronsMutationPolymerase Chain ReactionSequence Analysis, DNATranscription FactorsTumor Suppressor ProteinsCell Cycle ProteinsDNA PrimersPLAGL1 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID22784302
PMCPMC3422556
OpenAlexW1965924642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.